Peptides101

Peptide tracker

44 peptides. Two questions, asked separately: what is its legal status, and what does the evidence actually show? Every answer links to the primary document it came from.

Last verified No dosing informationGet this as JSON

These columns are independent, and that is the point. FDA status answers whether a drug is approved. The 503A column answers a different question — whether a substance may be used in pharmacy compounding — and it is blank for compounds that were never part of that process, because inventing a status would assert a proceeding they were never in. Neither column is a safety rating. A substance can be flagged for safety risks and still have real clinical trials behind it. Another can have strong evidence and no approval at all. Read them separately.

Showing 44 of 44

  • AOD-9604

    AOD9604, Anti-Obesity Drug 9604

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • ARA-290

    Cibinetide, ARA 290

    Not FDA-approvedCategory 3 — nominated without adequate supportPromising but unproven

    Verified

  • BPC-157

    Body Protection Compound 157, PL 14736

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • Cagrilintide

    CagriSema, cagrilintide-semaglutide

    In clinical developmentPromising but unproven

    Verified

  • CJC-1295

    CJC 1295, CJC-1295 with DAC

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • Desmopressin

    DDAVP, dDAVP

    FDA-approvedProven in humans

    Verified

  • Dulaglutide

    Trulicity, LY2189265

    FDA-approvedProven in humans

    Verified

  • Elamipretide

    SS-31, MTP-131

    FDA-approvedPromising but unproven

    Verified

  • Emideltide (DSIP)

    DSIP, Delta Sleep-Inducing Peptide

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • Epitalon

    Epithalon, AEDG peptide

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • Exenatide

    Byetta, Bydureon

    FDA-approvedProven in humans

    Verified

  • GHK-Cu

    Copper tripeptide-1, Glycyl-L-histidyl-L-lysine copper(II)

    Not FDA-approvedCategory 1 — under evaluationPromising but unproven

    Verified

  • Glucagon

    Baqsimi, Gvoke

    FDA-approvedProven in humans

    Verified

  • Gonadorelin

    GnRH, gonadotropin-releasing hormone

    FDA-approvedNot yet verified

    Verified

  • Ibutamoren

    MK-677, MK-0677

    Not FDA-approvedCategory 2 — significant safety risksPromising but unproven

    Verified

  • Icatibant

    Firazyr, icatibant acetate

    FDA-approvedProven in humans

    Verified

  • IGF-1 LR3

    Long R3 IGF-1, LongR3-IGF-I

    Not FDA-approvedAnimal or in-vitro only

    Verified

  • Ipamorelin

    Ipamorelin acetate, NNC 26-0161

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • Kisspeptin-10

    KP-10, Kisspeptin-112-121

    Not FDA-approvedCategory 2 — significant safety risksPromising but unproven

    Verified

  • KPV

    lysine-proline-valine, Lys-Pro-Val

    Not FDA-approvedWithdrawn from nominationAnimal or in-vitro only

    Verified

  • Leuprolide

    Lupron, Lupron Depot

    FDA-approvedProven in humans

    Verified

  • Linaclotide

    Linzess

    FDA-approvedProven in humans

    Verified

  • Liraglutide

    Victoza, Saxenda

    FDA-approvedProven in humans

    Verified

  • LL-37

    Cathelicidin LL-37, cathelicidin antimicrobial peptide

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • Mazdutide

    IBI362, LY3305677

    In clinical developmentProven in humans

    Verified

  • Melanotan II

    Melanotan 2, Melanotan-II

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • MOTS-c

    Mitochondrial Open Reading Frame of the 12S rRNA-c, MOTS-c acetate

    Not FDA-approvedWithdrawn from nominationAnimal or in-vitro only

    Verified

  • Octreotide

    Sandostatin, Sandostatin LAR Depot

    FDA-approvedProven in humans

    Verified

  • Oxytocin

    Pitocin, Syntocinon

    FDA-approvedNot yet verified

    Verified

  • PT-141 (Bremelanotide)

    PT-141, Bremelanotide

    FDA-approvedProven in humans

    Verified

  • Retatrutide

    LY3437943, Triple G

    In clinical developmentNever nominatedProven in humans

    Verified

  • Selank

    Selank acetate, TP-7

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • Semaglutide

    Ozempic, Wegovy

    FDA-approvedProven in humans

    Verified

  • Semax

    Semax acetate, Semax free base

    Not FDA-approvedWithdrawn from nominationAnimal or in-vitro only

    Verified

  • Sermorelin

    Sermorelin acetate, GEREF

    FDA approval withdrawnProven in humans

    Verified

  • Setmelanotide

    IMCIVREE, Imcivree

    FDA-approvedProven in humans

    Verified

  • Survodutide

    BI 456906, BI456906

    In clinical developmentProven in humans

    Verified

  • TB-500

    TB500, Thymosin Beta-4 Fragment 17-23

    Not FDA-approvedWithdrawn from nominationNo credible evidence

    Verified

  • Teriparatide

    Forteo, Bonsity

    FDA-approvedProven in humans

    Verified

  • Tesamorelin

    Tesamorelin acetate, TH9507

    FDA-approvedProven in humans

    Verified

  • Thymalin

    Timalin, Тималин

    Not FDA-approvedPromising but unproven

    Verified

  • Thymosin alpha-1

    Thymalfasin, Tα1

    Not FDA-approvedWithdrawn from nominationPromising but unproven

    Verified

  • Tirzepatide

    Mounjaro, Zepbound

    FDA-approvedProven in humans

    Verified

  • VIP

    Vasoactive Intestinal Peptide, Vasoactive Intestinal Polypeptide

    Not FDA-approvedCategory 1 — under evaluationPromising but unproven

    Verified

peptides101.com carries no advertising, accepts no sponsorship, sells no products, and earns no commission on anything we write about.

How we verify these, and what we refuse to publish, is in our editorial policy. If you find an error, tell us.